Akebia Therapeutics
AKBA
$1.34
Share price
0.75%
Change (1 day)
47.25%
Change (1 year)
Categories
EPS for Akebia Therapeutics (AKBA)
EPS in 2023 (TTM): -$0.64
According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.64. In 2022 the company made an earnings per share (EPS) of -$0.51 an increase over its 2021 EPS that were of -$1.70.
EPS history for Akebia Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.64 | 25.49% |
| 2022 | -$0.51 | -70% |
| 2021 | -$1.70 | -38.63% |
| 2020 | -$2.77 | 17.37% |
| 2019 | -$2.36 | 2.79% |
| 2018 | -$2.30 | 31.2% |
| 2017 | -$1.75 | -51.39% |
| 2016 | -$3.60 | 57.89% |
| 2015 | -$2.28 | -94.83% |
| 2014 | -$44.11 | 589.75% |
| 2013 | -$6.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -2,300.83% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -684.38% | 🇨🇭 Switzerland |
 Amgen AMGN | $14.15 | -2,310.94% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -$1.63 | 154.69% | 🇺🇸 USA |